Wangulu, C.; Zhao, D.; Zhou, Q.; Wei, C.; Kumar, R.; Schimmer, A.; Chang, H.
Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort. Cancers 2025, 17, 1405.
https://doi.org/10.3390/cancers17091405
AMA Style
Wangulu C, Zhao D, Zhou Q, Wei C, Kumar R, Schimmer A, Chang H.
Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort. Cancers. 2025; 17(9):1405.
https://doi.org/10.3390/cancers17091405
Chicago/Turabian Style
Wangulu, Collins, Davidson Zhao, Qianghua Zhou, Cuihong Wei, Rajat Kumar, Aaron Schimmer, and Hong Chang.
2025. "Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort" Cancers 17, no. 9: 1405.
https://doi.org/10.3390/cancers17091405
APA Style
Wangulu, C., Zhao, D., Zhou, Q., Wei, C., Kumar, R., Schimmer, A., & Chang, H.
(2025). Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort. Cancers, 17(9), 1405.
https://doi.org/10.3390/cancers17091405